Fecal transplant to treat recurring C. difficile infection
Part of Infections clinical trials.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Have C. difficile that keeps coming back (recurrent/relapsing) or is not improving with standard treatments.
- Have had specific treatment issues (like repeated episodes, or not responding after about a week of vancomycin).
- Be able and willing to give informed consent and follow study instructions.
- If you could get pregnant, use reliable birth control for up to 4 weeks after the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fecal microbiota transplantation (a transplant of healthy gut bacteria) works for people who get C. difficile infection repeatedly. It also focuses on collecting follow-up information to better understand which patients benefit and how.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This Phase 1 study tests a stool-based treatment approach for people who keep getting C. difficile diarrhea that returns after antibiotics. The goal is to see whether the treatment is safe and works to stop future episodes.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This trial tests whether one or multiple fecal transplants from a healthy donor can help treat both a recurring C. diff infection and active ulcerative colitis. It aims to find the best schedule for the procedure.
This Phase 2 study tests whether placing stool from a healthy donor into your gut can treat repeated, hard-to-control C. difficile colitis. It may help restore healthy gut bacteria and reduce future flare-ups.
Hear when a new Clostridium Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.